Stock report · Delisted · NYSE
Enfusion Inc (ENFN)
10.76USD Delisted Final close · Apr 17, 2025
ENFN no longer trades. Enfusion was acquired by Clearwater Analytics on April 18, 2025.
All prices on this page are historical. The last trade was on April 17, 2025, at $10.76.
ENFN stock price history
Final trading statistics
- Final close
- $10.76
- Final trading day
- Apr 17, 2025
- Market cap at delisting
- $1.02B
- Shares outstanding
- 94.80M
- Final 52-week range
- $7.83 – $11.80
- Avg. volume (final 3 mo.)
- 1,160,258
- All-time high
- $22.94 · Nov 2021
- All-time low
- $7.54 · May 2023
- Return since IPO
- -46.0%
- Beta
- 0.93
- Book value / share
- $0.77
- Price / book
- 13.90
About Enfusion Inc
Enfusion offered software-as-a-service for the investment management industry in the U.S., Europe, the Middle East, Africa and Asia Pacific. Its Portfolio Management System kept a real-time investment book of record with valuation and risk tools for investment chiefs and portfolio managers.
Its Order and Execution Management System let managers, traders, compliance staff and analysts send and manage orders across asset classes while enforcing rules. The Accounting/General Ledger System automated double-entry postings for cash and securities activity, and Enfusion Analytics supported portfolio analysis over time and automated reporting. It also provided managed services.
The company was founded in 1997 and based in Chicago, Illinois. Clearwater Analytics acquired Enfusion on April 18, 2025, and the last trade was on April 17, 2025 at $10.76.
- Exchange (former)
- NYSE
- Sector
- Technology
- Industry
- Software - Application
- Headquarters
- Chicago, IL
- Employees
- 1,143
- IPO date
- October 21, 2021
- Delisted
- April 18, 2025
- SEC CIK
- 1868912
Enfusion financials before the delisting
The last 5 fiscal years Enfusion reported as a public company, fiscal year ending December.
ENFN revenue and net income
ENFN earnings per share
ENFN annual financials
| Fiscal year | Revenue | Net income | EPS |
|---|---|---|---|
| FY2024 | $201.61M | $2.8M | $0.19 |
| FY2023 | $174.53M | $6.0M | $0.14 |
| FY2022 | $150.35M | −$13.3M | $0.18 |
| FY2021 | $111.70M | −$282.2M | −$137.64 |
| FY2020 | $79.56M | $4.1M | — |
Net income is GAAP. EPS is adjusted (non-GAAP) EPS, as reported.
Enfusion stock FAQ
What happened to Enfusion stock?
Enfusion was acquired by Clearwater Analytics on April 18, 2025. The final close was $10.76 on April 17, 2025.
Can I still buy ENFN stock?
No. ENFN is no longer listed on the NYSE or any other U.S. exchange; it was removed on April 18, 2025.
What was the last price of ENFN?
ENFN last closed at $10.76 on April 17, 2025, which valued the company at about $1.02B.
How did Enfusion do in its last full fiscal year?
In fiscal 2024, its last full year as a public company, Enfusion reported revenue of $201.61M and net income of $2.8M.
When did Enfusion go public?
Enfusion shares started trading on October 21, 2021.
ENFN no longer trades, so there is no live quote. The information on this page is for reference only and is not investment advice; see our disclaimer.